Bandaram Pharma Packtech Limited
BSE: BANDARAM · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Bandaram Pharma Packtech Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Bandaram Pharma Pack Limited specialises in the manufacturing and distribution of packaging solutions tailored for the pharmaceutical and healthcare sectors. The company focuses on ensuring regulatory compliance and protecting medicinal products from environmental contamination.
Business Model
The company generates revenue through the production and supply of specialised pharmaceutical packaging materials. It operates as a niche service provider within the pharmaceutical supply chain, catering to the specific safety and quality requirements of healthcare clients.
Management Commentary
Management is focused on exploring new opportunities within the broader healthcare sector to diversify revenue streams. The company aims to enhance its market presence within the competitive domestic landscape.
Growth Outlook
Growth is expected to be driven by the expansion of service offerings and the pursuit of diversification strategies within the healthcare industry. The company is actively seeking to strengthen its position as a reliable partner in the pharmaceutical supply chain.
Key Risks
- Regulatory Compliance. Failure to adhere to stringent pharmaceutical packaging standards could lead to product recalls and loss of business.
- Market Competition. The domestic pharmaceutical packaging market is highly competitive, which may exert pressure on profit margins.
- Raw Material Price Volatility. Fluctuations in the cost of raw materials used in packaging production can adversely impact the company's operating costs.
Start your research today
Unlock AI insights, financials, peers and live data on Bandaram Pharma Packtech Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Bandaram Pharma Packtech LimitedBANDARAM | ₹32 Cr | — | — | — | 4.6% | — | — | -43.8% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,830 Cr | 18.76 | 8.80 | 10.2% | 32.5% | 10.5% | 13.3% | -28.5% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,772 Cr | 48.60 | 16.73 | 22.5% | 32.7% | 15.8% | 18.6% | +14.0% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,237 Cr | 20.61 | 14.59 | 41.9% | 58.0% | 21.2% | 26.3% | +0.5% |
One Global Service Provider LimitedONEGLOBAL | ₹1,068 Cr | — | — | — | 19.0% | — | — | +114.9% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹886 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Bandaram Pharma Packtech Limited
BSE: BANDARAM · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Bandaram Pharma Packtech Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Bandaram Pharma Pack Limited specialises in the manufacturing and distribution of packaging solutions tailored for the pharmaceutical and healthcare sectors. The company focuses on ensuring regulatory compliance and protecting medicinal products from environmental contamination.
Business Model
The company generates revenue through the production and supply of specialised pharmaceutical packaging materials. It operates as a niche service provider within the pharmaceutical supply chain, catering to the specific safety and quality requirements of healthcare clients.
Management Commentary
Management is focused on exploring new opportunities within the broader healthcare sector to diversify revenue streams. The company aims to enhance its market presence within the competitive domestic landscape.
Growth Outlook
Growth is expected to be driven by the expansion of service offerings and the pursuit of diversification strategies within the healthcare industry. The company is actively seeking to strengthen its position as a reliable partner in the pharmaceutical supply chain.
Key Risks
- Regulatory Compliance. Failure to adhere to stringent pharmaceutical packaging standards could lead to product recalls and loss of business.
- Market Competition. The domestic pharmaceutical packaging market is highly competitive, which may exert pressure on profit margins.
- Raw Material Price Volatility. Fluctuations in the cost of raw materials used in packaging production can adversely impact the company's operating costs.
Start your research today
Unlock AI insights, financials, peers and live data on Bandaram Pharma Packtech Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026